IGMS
IGM Biosciences
IGMS
IGMS
Delisted
IGMS was delisted on the 13th of August, 2025.
109 hedge funds and large institutions have $1.38B invested in IGM Biosciences in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 40 increasing their positions, 34 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
109
Holders Change
+2
Holders Change %
+1.87%
% of All Funds
1.92%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
16
Increased
40
Reduced
34
Closed
14
Calls
$7.08M
Puts
$27.5M
Net Calls
-$20.4M
Net Calls Change
+$7.76M
Top Buyers
| 1 |
Goldman Sachs
New York
|
$56.8M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$138M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
$22.5M |
| 4 |
State Street
Boston,
Massachusetts
|
$52.7M |
| 5 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
$14.1M |
